<DOC>
	<DOCNO>NCT00401999</DOCNO>
	<brief_summary>This study examine relationship variation gene call OPRM1 response alcohol . The OPRM1 ( Mu-opioid Receptor-1 ) gene help regulate brain pathway involve experiencing pleasure . Brain pathway use chemical call dopamine . Different form OPRM1 gene may lead difference dopamine release subsequently differences person 's response alcohol . Healthy non-smokers 21 45 year age may eligible study . Candidates screen medical psychiatric history physical examination , blood urine test , breathalyzer ( breath alcohol test ) . A blood test also do determine variant OPRM1 gene . Participants undergo follow procedure three study session : Session 1 `` Breathalyzer test , urine test illicit drug pregnancy test woman become pregnant. `` Insertion catheter ( plastic tube ) vein one arm infusing alcohol arm drawing blood samples. `` Completion questionnaire intoxicate subject feels. `` Blood draw research studies. `` Eye movement test ( visor digital camera track subject 's eye movement watch light computer screen ) . `` 45-minute alcohol infusion ( 0,08 gram per deciliter - level consider state drive influence alcohol ) . `` Repeat breathalyzer , questionnaire , eye movement test blood draw every 15 minute infusion infusion complete. `` Subjects remain clinic blood alcohol content fall 0.02 g/dL , determine breathalyzer test do every 15 minute . Subjects usually return home 3 4 hour alcohol infusion stop . Sessions 2 3 The procedure session 1 , except subject receive infusion alcohol one session infusion saline ( salt water ) . Also , subject undergo positron emission tomography ( PET ) scan infusion . For test , subject lie bed slide doughnut-shaped scanner . A custom-molded mask use support head prevent move scan . A small amount radioactive substance call C-11 raclopride inject one catheter trace brain dopamine activity .</brief_summary>
	<brief_title>OPRM1 A118G SNP , Alcohol Response , Striatal Dopamine</brief_title>
	<detailed_description>Objectives : Reinforcing property alcohol part mediate endogenous opioids . Mesolimbic dopamine ( DA ) release key signal drug reward , endogenous opioids think exert effect modulate activity system . A functional mu-opioid receptor ( OPRM1 ) A118G single nucleotide polymorphism ( SNP ) alters affinity mu-opioid receptor endogenous ligand , study associate increase risk alcohol heroin addiction , confers differential pain sensitivity subjective response alcohol . This prompts question whether differential subjective response alcohol observe function OPRM1 A118G genotype reflect differential activation mesolimbic DA release . The objective study examine role A118G OPRM1 polymorphism responses highly standardize intravenous alcohol challenge , regard psycho-physiological variable measure laboratory , brain dopamine release measure 11C raclopride PET . Study Population : We screen healthy participant general population obtain sample two group subject : 1 ) person homozygous major 118A allele ( 118AA genotype ) ; 2 ) person carry one two copy variant 118G allele ( 118AG 118GG genotype , hereafter call 118GX ) . Design Outcome Measures : We compare response group standardize alcohol challenge use procedure place NIAAA protocols 03-AA-0283 Influence Age Gender Alcohol Metabolism Acute Responses 04-AA-0060 The Effect Ethanol Cerebral Blood Flow Measured Functional Magnetic Resonance Imaging Development Conditioned Response Ethanol Administration . Participants give standardized IV infusion alcohol solution infuse achieve maintain target blood alcohol level 80 mg % . Pre post infusion measure make two area : 1 ) subjective response measure standardized questionnaire , 2 ) measure physiologic response , include saccadic eye movement blood chemistry . We hypothesize 118GX subject significantly higher subjective response alcohol challenge 118AA subject . We repeat alcohol infusion procedure participant twice PET scanner , infuse alcohol saline , assess displacement 11C raclopride , positron emitter label ligand bind preferentially D2 receptor . We hypothesize 118GX subject 11C raclopride displacement alcohol infusion relative placebo , indicate great amount dopamine release .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Male female participant 2145 year age . 2 . Good health determine medical history , physical exam , EKG lab test . 3 . Social drinker consume less 20 alcoholic beverage per week , average , normal liver enzyme seek treatment alcoholrelated problem . 4 . Current nonsmoker never smoke quit least year prior enrol study . 5 . Females normal menstrual cycle test follicular phase cycle ( within 15 day offset menses ) must negative urine pregnancy ( hCG ) test start study session . 6 . An equal number final participant OPRM1 118 A/A vs. 118A/G 118G/G genotype . EXCLUSION CRITERIA : 1 . Current prior history significant disease , include cardiovascular , respiratory , gastrointestinal , hepatic , renal , endocrine , reproductive disorder , positive hepatitis HIV test screening . 2 . Current AxisI psychiatric illness . 3 . Current prior history alcohol drug dependence , well nondrinker ( alcoholnaive individual current abstainer ) . 4 . Positive result urine screen illicit drug . 5 . Nursing , pregnancy intention become pregnant woman . Female participant undergo clinical interview urine betahCG test ensure pregnant . If possible document nonpregnancy , study perform . 6 . Inability undergo MRI scan brain due claustrophobia anxiety confine small space magnet bore , due presence metallic implant . 7 . Use prescription OTC medication know interact alcohol within 2 week study . These include , may limit : isosorbide , nitroglycerine , benzodiazepine , warfarin , antidepressant amitriptyline , clomipramine nefazodone , antidiabetes medication glyburide , metformin tolbutamide , H2antagonists heartburn cimetidine ranitidine , muscle relaxant , antiepileptic include phenytoin phenobarbital codeine , narcotic include darvocet , percocet hydrocodone . Drugs known inhibit induce enzyme metabolize alcohol use 4 week prior study . These include chlorzoxazone , isoniazid , metronidazole disulfiram . Coughandcold preparation contain antihistamine , pain medicine antiinflammatories aspirin , ibuprofen , acetaminophen , celecoxib naproxen , withhold least 72 hour prior study session . 8 . Selfreported history flush upon intake alcohol .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 28, 2011</verification_date>
	<keyword>PET</keyword>
	<keyword>C-11 Raclopride</keyword>
	<keyword>Dopamine</keyword>
	<keyword>OPRM1</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>